News & innovation

Partner news // 6.01.19

Miiskin offers free patient’s leaflets for use by Dermatology clinics

Miiskin, the leading skin checking app, is delighted to offer free patient educational leaflets to any dermatology clinic who might find them useful for their patients.  Miiskin became the first app to receive independent dermatological accreditation from the Skin Health Alliance in 2018.

Skin cancer is the most common form of cancer in the UK, and rates continue to rise. At least 100,000 new cases are now diagnosed each year, and the disease kills over 2,500 people each year in the UK – that’s seven people every day.  Early detection is the best defence against skin cancer, and regularly checking your skin for changes is recommended.

The helpful leaflet, which can be requested from https://miiskin.com/doctors/ or by emailing doctors@miiskin.com , advises patients about keeping track of changes to their skin and moles, signs to look out for in moles and how to protect themselves in the sun.

The Miiskin app was created to help people track changes to skin and moles over time by using photographs.  It provides reminders to routinely check for changes and information about the types of things to look for. In addition, the app assists the user in comparing photographs over time by allowing side-by-side image comparisons – helping people to identify differences between photos, such as the appearance of a new mole or a change to an existing one.  Miiskin does not try to diagnose skin cancer or tell users that they are at risk or not. People who spot changes should seek advice from their GP or dermatologist.

Prof Chris Bunker, former president of the British Association of Dermatologists and Consultant Dermatologist at University College London Hospital said: “It’s important to stay vigilant in paying attention to changes in moles and marks on your skin. People should regularly examine their skin to track any changes, use photos to keep records of the skin’s appearance and show these photos to their doctor if worrying changes are seen.  Miiskin offers a sensible solution to facilitate this approach.”